glp-1 synergizer Medications for Weight Loss Swiss Re says GLP-1 drugs
Description
About 10% of participants on the highest dose discontinued treatment due to their adverse events, compared to 5% of those on placebo
Microdosing requires compounded tirzepatide
Medical studies indicate that up to 40% of the weight loss with GLP-1s is from lean muscle mass
Although GLP-1 agonists have many positive benefits, they do have a number of potential side effects
Recognizing these factors is crucial as we navigate the complexities of treatment pricing, especially with the anticipated changes in 2025
